JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.97B |
| 2 |
Vanguard Total Bond Market
BND
|
+$1.96B |
| 3 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.61B |
| 4 |
UnitedHealth
UNH
|
+$1.1B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.25B |
| 2 |
Centene
CNC
|
+$827M |
| 3 |
Amazon
AMZN
|
+$791M |
| 4 |
Texas Instruments
TXN
|
+$716M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$569M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.52% |
| 2 | Technology | 14.62% |
| 3 | Healthcare | 12.48% |
| 4 | Financials | 10.51% |
| 5 | Consumer Discretionary | 8.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
PNC Financial Services
PNC
$87.6B
| $1.68B | 0.24% |
11,263,780
+100,382
| +0.9% | +$16.3M |
2013 Q2
37 quarters
|
|
102
Mondelez International
MDLZ
$77.4B
| $1.67B | 0.24% |
30,472,735
-1,623,221
| -5% | -$101M |
2013 Q2
37 quarters
|
|
|
103
Centene
CNC
$31.9B
| $1.61B | 0.23% |
20,689,916
-9,254,103
| -31% | -$827M |
2013 Q2
37 quarters
|
|
104
iShares Russell 1000 Growth ETF
IWF
$130B
| $1.59B | 0.23% |
30,154,684
+517,240
| +2% | +$30.4M |
2013 Q2
37 quarters
|
|
105
CME Group
CME
$99.4B
| $1.57B | 0.23% |
8,864,338
+2,237,145
| +34% | +$442M |
2013 Q2
37 quarters
|
|
106
Intuitive Surgical
ISRG
$147B
| $1.56B | 0.22% |
8,330,852
+72,982
| +0.9% | +$15.7M |
2013 Q2
37 quarters
|
|
107
Linde
LIN
$222B
| $1.56B | 0.22% |
5,772,547
-9,346
| -0.2% | -$2.68M |
2018 Q4
15 quarters
|
|
108
TJX Companies
TJX
$153B
| $1.56B | 0.22% |
25,034,391
-714,396
| -3% | -$44.9M |
2013 Q2
37 quarters
|
|
109
Dover
DOV
$25.4B
| $1.55B | 0.22% |
13,266,969
-121,771
| -0.9% | -$15.5M |
2013 Q2
37 quarters
|
|
110
Nike
NKE
$51.6B
| $1.53B | 0.22% |
18,451,484
+161,774
| +0.9% | +$17.4M |
2013 Q2
37 quarters
|
|
111
iShares MSCI Japan ETF
EWJ
$23.8B
| $1.52B | 0.22% |
31,120,691
+1,057,575
| +4% | +$56.6M |
2013 Q2
37 quarters
|
|
112
General Dynamics
GD
$89.3B
| $1.51B | 0.22% |
7,119,221
+23,025
| +0.3% | +$5.2M |
2013 Q2
37 quarters
|
|
113
Walmart Inc
WMT
$877B
| $1.51B | 0.22% |
34,920,843
-5,164,038
| -13% | -$226M |
2013 Q2
37 quarters
|
|
114
iShares 1-3 Year Treasury Bond ETF
SHY
$26.4B
| $1.5B | 0.21% |
18,415,049
+3,259,505
| +22% | +$268M |
2013 Q2
37 quarters
|
|
115
Synopsys
SNPS
$95.4B
| $1.49B | 0.21% |
4,862,681
+108,936
| +2% | +$36.9M |
2013 Q2
37 quarters
|
|
116
Lam Research
LRCX
$401B
| $1.42B | 0.2% |
38,742,010
-5,476,070
| -12% | -$244M |
2013 Q2
37 quarters
|
|
117
Vanguard Information Technology ETF
VGT
$156B
| $1.42B | 0.2% |
36,871,392
+1,417,360
| +4% | +$62.3M |
2014 Q2
33 quarters
|
|
118
Vertex Pharmaceuticals
VRTX
$128B
| $1.41B | 0.2% |
4,859,687
-377,855
| -7% | -$109M |
2013 Q2
37 quarters
|
|
119
iShares 3-7 Year Treasury Bond ETF
IEI
$16.9B
| $1.4B | 0.2% |
12,264,136
+1,206,966
| +11% | +$143M |
2013 Q2
37 quarters
|
|
120
T-Mobile US
TMUS
$184B
| $1.35B | 0.19% |
9,588,887
+388,520
| +4% | +$54.6M |
2013 Q2
37 quarters
|
|
|
AMJ
121
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| $1.34B | 0.19% |
66,586,852
+2,751,361
| +4% | +$57.6M |
2013 Q2
37 quarters
|
|
122
Honeywell
HON
$65.5B
| $1.33B | 0.19% |
8,468,122
+3,119,552
| +58% | +$543M |
2013 Q2
37 quarters
|
|
123
Amgen
AMGN
$220B
| $1.33B | 0.19% |
5,901,929
-199,898
| -3% | -$48.5M |
2013 Q2
37 quarters
|
|
124
PUT
Apple
AAPL
$4.97T
| $1.33B | 0.19% |
9,619,300
+418,900
| +5% | +$65.7M |
2013 Q2
37 quarters
|
|
125
Infosys
INFY
$43.3B
| $1.32B | 0.19% |
77,701,774
+1,024,966
| +1% | +$19.2M |
2013 Q2
37 quarters
|
|
Similar funds
JP Morgan Chase's Q3 2022 Portfolio in Review
As of Q3 2022, JP Morgan Chase held 7,216 positions worth $696B, down 3% from $718B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q3 2022 filing shows 556 new, 2,573 increased, 2,583 reduced and 516 closed positions. Its largest new stake was Franklin FTSE Japan ETF: 3,003,780 shares worth $65.1M. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $1.25B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q3 2022 buy was Franklin FTSE Japan ETF: 3,003,780 shares worth $65.1M.
- JP Morgan Chase added most to Invesco QQQ Trust in Q3 2022, an estimated $1.97B increase.
- JP Morgan Chase's biggest Q3 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $1.25B.
- JP Morgan Chase fully exited CMC Materials, Inc. Common Stock in Q3 2022, selling an estimated $248M.
- JP Morgan Chase's ten largest holdings make up 17% of its $696B portfolio in Q3 2022.
- JP Morgan Chase opened 556 new positions and closed 516 in Q3 2022.
- JP Morgan Chase's portfolio value fell 3% quarter-over-quarter to $696B.
Based on JP Morgan Chase's 13F filing for Q3 2022, filed 14 Nov 2022.